EEG biomarkers in Alzheimer's and prodromal Alzheimer's: a comprehensive analysis of spectral and connectivity features.


Journal

Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 30 04 2024
accepted: 27 09 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Biomarkers of Alzheimer's disease (AD) and mild cognitive impairment (MCI, or prodromal AD) are highly significant for early diagnosis, clinical trials and treatment outcome evaluations. Electroencephalography (EEG), being noninvasive and easily accessible, has recently been the center of focus. However, a comprehensive understanding of EEG in dementia is still needed. A primary objective of this study is to investigate which of the many EEG characteristics could effectively differentiate between individuals with AD or prodromal AD and healthy individuals. We collected resting state EEG data from individuals with AD, prodromal AD, and normal cognition. Two distinct preprocessing pipelines were employed to study the reliability of the extracted measures across different datasets. We extracted 41 different EEG features. We have also developed a stand-alone software application package, Feature Analyzer, as a comprehensive toolbox for EEG analysis. This tool allows users to extract 41 EEG features spanning various domains, including complexity measures, wavelet features, spectral power ratios, and entropy measures. We performed statistical tests to investigate the differences in AD or prodromal AD from age-matched cognitively normal individuals based on the extracted EEG features, power spectral density (PSD), and EEG functional connectivity. Spectral power ratio measures such as theta/alpha and theta/beta power ratios showed significant differences between cognitively normal and AD individuals. Theta power was higher in AD, suggesting a slowing of oscillations in AD; however, the functional connectivity of the theta band was decreased in AD individuals. In contrast, we observed increased gamma/alpha power ratio, gamma power, and gamma functional connectivity in prodromal AD. Entropy and complexity measures after correcting for multiple electrode comparisons did not show differences in AD or prodromal AD groups. We thus catalogued AD and prodromal AD-specific EEG features. Our findings reveal that the changes in power and connectivity in certain frequency bands of EEG differ in prodromal AD and AD. The spectral power, power ratios, and the functional connectivity of theta and gamma could be biomarkers for diagnosis of AD and prodromal AD, measure the treatment outcome, and possibly a target for brain stimulation.

Sections du résumé

BACKGROUND BACKGROUND
Biomarkers of Alzheimer's disease (AD) and mild cognitive impairment (MCI, or prodromal AD) are highly significant for early diagnosis, clinical trials and treatment outcome evaluations. Electroencephalography (EEG), being noninvasive and easily accessible, has recently been the center of focus. However, a comprehensive understanding of EEG in dementia is still needed. A primary objective of this study is to investigate which of the many EEG characteristics could effectively differentiate between individuals with AD or prodromal AD and healthy individuals.
METHODS METHODS
We collected resting state EEG data from individuals with AD, prodromal AD, and normal cognition. Two distinct preprocessing pipelines were employed to study the reliability of the extracted measures across different datasets. We extracted 41 different EEG features. We have also developed a stand-alone software application package, Feature Analyzer, as a comprehensive toolbox for EEG analysis. This tool allows users to extract 41 EEG features spanning various domains, including complexity measures, wavelet features, spectral power ratios, and entropy measures. We performed statistical tests to investigate the differences in AD or prodromal AD from age-matched cognitively normal individuals based on the extracted EEG features, power spectral density (PSD), and EEG functional connectivity.
RESULTS RESULTS
Spectral power ratio measures such as theta/alpha and theta/beta power ratios showed significant differences between cognitively normal and AD individuals. Theta power was higher in AD, suggesting a slowing of oscillations in AD; however, the functional connectivity of the theta band was decreased in AD individuals. In contrast, we observed increased gamma/alpha power ratio, gamma power, and gamma functional connectivity in prodromal AD. Entropy and complexity measures after correcting for multiple electrode comparisons did not show differences in AD or prodromal AD groups. We thus catalogued AD and prodromal AD-specific EEG features.
CONCLUSIONS CONCLUSIONS
Our findings reveal that the changes in power and connectivity in certain frequency bands of EEG differ in prodromal AD and AD. The spectral power, power ratios, and the functional connectivity of theta and gamma could be biomarkers for diagnosis of AD and prodromal AD, measure the treatment outcome, and possibly a target for brain stimulation.

Identifiants

pubmed: 39449097
doi: 10.1186/s13195-024-01582-w
pii: 10.1186/s13195-024-01582-w
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236

Subventions

Organisme : This work was supported by the CBR start-up fund (CA) and the India Alliance DBT Wellcome Trust grant (IA/I/22/1/506257; CA)
ID : IA/I/22/1/506257

Informations de copyright

© 2024. The Author(s).

Références

(2023). 2023 Alzheimer’s disease facts and figures. Alzheimer’s Dement. https://doi.org/10.1002/alz.13016
Rowley PA, et al. Amyloid and tau PET imaging of Alzheimer Disease and other neurodegenerative conditions. Seminars Ultrasound CT MRI. 2020. https://doi.org/10.1053/j.sult.2020.08.011 .
doi: 10.1053/j.sult.2020.08.011
Frontzkowski L, et al. Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading. Nat Commun. 2022. https://doi.org/10.1038/s41467-022-32592-7 .
doi: 10.1038/s41467-022-32592-7 pubmed: 35987901 pmcid: 9392750
Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017. https://doi.org/10.1038/nature21029 .
doi: 10.1038/nature21029 pubmed: 28959956 pmcid: 5641217
van de Haar HJ et al. (2016). Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. Radiology. https://doi.org/10.1148/radiol.2016152244
Bastin C, et al. In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography. Eur J Nucl Med Mol Imaging. 2020. https://doi.org/10.1007/s00259-019-04461-x .
doi: 10.1007/s00259-019-04461-x pubmed: 31468182
Wharton W, et al. Neurofibrillary tangles and Conversion to mild cognitive impairment with certain antihypertensives. J Alzheimer’s Disease. 2019. https://doi.org/10.3233/JAD-190011 .
doi: 10.3233/JAD-190011
Hatashita S, Wakebe D. Amyloid-β deposition and long-term progression in mild cognitive impairment due to Alzheimer’s Disease defined with amyloid PET imaging. J Alzheimer’s Disease. 2017. https://doi.org/10.3233/JAD-161074 .
doi: 10.3233/JAD-161074
Cho H, et al. Tau PET in Alzheimer disease and mild cognitive impairment. Neurology. 2016. https://doi.org/10.1212/WNL.0000000000002892 .
doi: 10.1212/WNL.0000000000002892 pubmed: 27358341 pmcid: 4837543
Bejanin A, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease. Brain. 2017. https://doi.org/10.1093/brain/awx243 .
doi: 10.1093/brain/awx243 pubmed: 29053874 pmcid: 5841139
Gonzalez-Ortiz F, et al. Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration. Brain. 2023. https://doi.org/10.1093/brain/awac407 .
doi: 10.1093/brain/awac407 pubmed: 36572122
Hwang G, et al. EEG correlates of verbal and nonverbal working memory. Behav Brain Funct. 2005. https://doi.org/10.1186/1744-9081-1-20 .
doi: 10.1186/1744-9081-1-20 pubmed: 16287504 pmcid: 1315326
Pedroni A, et al. Automagic: standardized preprocessing of big EEG data. NeuroImage. 2019. https://doi.org/10.1016/j.neuroimage.2019.06.046 .
doi: 10.1016/j.neuroimage.2019.06.046 pubmed: 31233907
Tait L, et al. EEG microstate complexity for aiding early diagnosis of Alzheimer’s disease. Sci Rep. 2020. https://doi.org/10.1038/s41598-020-74790-7 .
doi: 10.1038/s41598-020-74790-7 pubmed: 33077823 pmcid: 7572485
Ma MK-H, et al. Regularity and randomness in ageing: differences in resting-state EEG complexity measured by largest Lyapunov exponent. Neuroimage: Rep. 2021. https://doi.org/10.1016/j.ynirp.2021.100054 .
doi: 10.1016/j.ynirp.2021.100054
Safi MS, Safi SMM. Early detection of Alzheimer’s disease from EEG signals using Hjorth parameters. Biomed Signal Process Control. 2021. https://doi.org/10.1016/j.bspc.2020.102338 .
doi: 10.1016/j.bspc.2020.102338
Şeker M, et al. Complexity of EEG Dynamics for early diagnosis of Alzheimer’s Disease using permutation Entropy Neuromarker. Comput Methods Programs Biomed. 2021. https://doi.org/10.1016/j.cmpb.2021.106116 .
doi: 10.1016/j.cmpb.2021.106116 pubmed: 33957376
Maturana-Candelas A, et al. EEG characterization of the Alzheimer’s Disease Continuum by means of Multiscale Entropies. Entropy. 2019. https://doi.org/10.3390/e21060544 .
doi: 10.3390/e21060544 pubmed: 33267258 pmcid: 7515033
Shim Y, et al. Electroencephalography for early detection of Alzheimer’s Disease in Subjective Cognitive decline. Dement Neurocognitive Disorders. 2022. https://doi.org/10.12779/dnd.2022.21.4.126 .
doi: 10.12779/dnd.2022.21.4.126
Flores-Sandoval AA, et al. Spectral power ratio as a measure of EEG changes in mild cognitive impairment due to Alzheimer’s disease: a case-control study. Neurobiol Aging. 2023. https://doi.org/10.1016/j.neurobiolaging.2023.05.010 .
doi: 10.1016/j.neurobiolaging.2023.05.010 pubmed: 37459658 pmcid: 10614059
Locatelli T, et al. EEG coherence in Alzheimer’s disease. Electroencephalogr Clin Neurophysiol. 1998. https://doi.org/10.1016/S0013-4694(97)00129-6 .
doi: 10.1016/S0013-4694(97)00129-6 pubmed: 9743281
Aoki Y, et al. EEG resting-state networks in Alzheimer’s disease associated with clinical symptoms. Sci Rep. 2023. https://doi.org/10.1038/s41598-023-30075-3 .
doi: 10.1038/s41598-023-30075-3 pubmed: 38129496 pmcid: 10739745
Sabbagh MN, et al. FDA position statement early Alzheimer’s disease: developing drugs for treatment, Guidance for Industry. Alzheimer’s Dementia: Translational Res Clin Interventions. 2019. https://doi.org/10.1016/j.trci.2018.11.004 .
doi: 10.1016/j.trci.2018.11.004
Güntekin B, et al. Alterations of resting-state Gamma frequency characteristics in aging and Alzheimer’s disease. Cogn Neurodyn. 2023. https://doi.org/10.1007/s11571-022-09873-4 .
doi: 10.1007/s11571-022-09873-4 pubmed: 37974589
Miltiadous A and Katerina D. Tzimourta and Theodora Afrantou and Panagiotis Ioannidis and Nikolaos Grigoriadis and, Dimitrios G, Tsalikakis, Angelidis P, Tsipouras MG. E.G. and N.G. and A.T.T.\; (2024). A dataset of EEG recordings from: Alzheimer’s disease, Frontotemporal dementia and Healthy subjects.
Robbins KA, et al. How sensitive are EEG results to preprocessing methods: a Benchmarking Study. IEEE Trans Neural Syst Rehabil Eng. 2020. https://doi.org/10.1109/TNSRE.2020.2980223 .
doi: 10.1109/TNSRE.2020.2980223 pubmed: 32217478
Coelli S, et al. Selecting methods for a modular EEG pre-processing pipeline: an objective comparison. Biomed Signal Process Control. 2024. https://doi.org/10.1016/j.bspc.2023.105830 .
doi: 10.1016/j.bspc.2023.105830
Islam MK, et al. Methods for artifact detection and removal from scalp EEG: a review. Neurophysiologie Clinique/Clinical Neurophysiol. 2016. https://doi.org/10.1016/j.neucli.2016.07.002 .
doi: 10.1016/j.neucli.2016.07.002
Chang C-Y, et al. Evaluation of Artifact Subspace Reconstruction for Automatic Artifact Components removal in Multi-channel EEG recordings. IEEE Trans Biomed Eng. 2020. https://doi.org/10.1109/TBME.2019.2930186 .
doi: 10.1109/TBME.2019.2930186 pubmed: 32813645 pmcid: 7606319
de Cheveigné A, Arzounian D. Robust detrending, rereferencing, outlier detection, and inpainting for multichannel data. NeuroImage. 2018. https://doi.org/10.1016/j.neuroimage.2018.01.035 .
doi: 10.1016/j.neuroimage.2018.01.035 pubmed: 30496819
Fujiwara K, et al. Sleep-EEG-based parameters for discriminating fatigue and sleepiness. Front Sleep. 2022. https://doi.org/10.3389/frsle.2022.975415 .
doi: 10.3389/frsle.2022.975415
Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004. https://doi.org/10.1016/j.jneumeth.2003.10.009 .
doi: 10.1016/j.jneumeth.2003.10.009 pubmed: 15102499
Dagar M et al. (2018). Performance Comparison of Hampel and Median Filters in Removing Deep Brain Stimulation Artifact, pp. 17–28.
Bokil H, et al. Chronux: a platform for analyzing neural signals. J Neurosci Methods. 2010. https://doi.org/10.1016/j.jneumeth.2010.06.020 .
doi: 10.1016/j.jneumeth.2010.06.020 pubmed: 20637804 pmcid: 2934871
Kothe. (2015). Artifact removal technique with signal reconstruction. issued 2015.
Willison. (1963). J.Physiology.
Giannakopoulos T, Pikrakis A. Audio features. Introduction to Audio Analysis. Elsevier; 2014. pp. 59–103. https://doi.org/10.1016/C2012-0-03524-7 .
Tripathy RK, et al. Analysis of physiological signals using state space correlation entropy. Healthc Technol Lett. 2017. https://doi.org/10.1049/htl.2016.0065 .
doi: 10.1049/htl.2016.0065 pubmed: 28894589 pmcid: 5437706
Richman JS, Moorman JR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol. 2000. https://doi.org/10.1152/ajpheart.2000.278.6.H2039 .
doi: 10.1152/ajpheart.2000.278.6.H2039 pubmed: 10843903
Germán-Salló Z. Measuring the complexity of Discrete signals. Procedia Manuf. 2020. https://doi.org/10.1016/j.promfg.2020.03.080 .
doi: 10.1016/j.promfg.2020.03.080
Choi J, et al. Resting-state prefrontal EEG biomarkers in correlation with MMSE scores in elderly individuals. Sci Rep. 2019. https://doi.org/10.1038/s41598-019-46789-2 .
doi: 10.1038/s41598-019-46789-2 pubmed: 31892717 pmcid: 6938477
Baik K, et al. Implication of EEG theta/alpha and theta/beta ratio in Alzheimer’s and Lewy body disease. Sci Rep. 2022. https://doi.org/10.1038/s41598-022-21951-5 .
doi: 10.1038/s41598-022-21951-5 pubmed: 36470993 pmcid: 9722682
Özbek Y, et al. Resting-state EEG alpha/theta power ratio discriminates early-onset Alzheimer’s disease from healthy controls. Clin Neurophysiol. 2021. https://doi.org/10.1016/j.clinph.2021.05.012 .
doi: 10.1016/j.clinph.2021.05.012 pubmed: 34284236
AlSharabi K, et al. EEG Signal Processing for Alzheimer’s disorders using Discrete Wavelet Transform and Machine Learning approaches. IEEE Access. 2022. https://doi.org/10.1109/ACCESS.2022.3198988 .
doi: 10.1109/ACCESS.2022.3198988
Oostenveld R, et al. FieldTrip: Open Source Software for Advanced Analysis of MEG, EEG, and Invasive Electrophysiological Data. Comput Intell Neurosci. 2011. https://doi.org/10.1155/2011/156869 .
doi: 10.1155/2011/156869 pubmed: 21822426 pmcid: 3148593
Vinck M, et al. The pairwise phase consistency: a bias-free measure of rhythmic neuronal synchronization. NeuroImage. 2010. https://doi.org/10.1016/j.neuroimage.2010.01.073 .
doi: 10.1016/j.neuroimage.2010.01.073 pubmed: 20114076
Hollander M, et al. Nonparametric statistical methods. Wiley; 2015.
(2011). Nonparametric Statistical Inference by GIBBONS, J. D. and CHAKRABORTI S. Biometrics. https://doi.org/10.1111/j.1541-0420.2011.01658_9.x
Benjamini Y, Hochberg Y. Controlling the false Discovery rate: a practical and powerful Approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x .
doi: 10.1111/j.2517-6161.1995.tb02031.x
Sedgwick P. Spearman’s rank correlation coefficient. BMJ. 2014. https://doi.org/10.1136/bmj.g7327 .
doi: 10.1136/bmj.g7327 pubmed: 25527114
Benz N, et al. Slowing of EEG background activity in Parkinson’s and Alzheimer’s disease with early cognitive dysfunction. Front Aging Neurosci. 2014. https://doi.org/10.3389/fnagi.2014.00314 .
doi: 10.3389/fnagi.2014.00314 pubmed: 25477817 pmcid: 4235380
Wiesman AI, et al. Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer’s disease. Brain. 2022. https://doi.org/10.1093/brain/awab430 .
doi: 10.1093/brain/awab430 pubmed: 35088842 pmcid: 9246709
Moretti D. Individual analysis of EEG frequency and band power in mild Alzheimer’s disease. Clin Neurophysiol. 2004. https://doi.org/10.1016/S1388-2457(03)00345-6 .
doi: 10.1016/S1388-2457(03)00345-6 pubmed: 14744569
Coben LA, et al. Frequency analysis of the resting awake EEG in mild senile dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol. 1983. https://doi.org/10.1016/0013-4694(83)90124-4 .
doi: 10.1016/0013-4694(83)90124-4 pubmed: 6187529
Murty DV, et al. Stimulus-induced gamma rhythms are weaker in human elderly with mild cognitive impairment and Alzheimer’s disease. eLife. 2021. https://doi.org/10.7554/eLife.61666 .
doi: 10.7554/eLife.61666 pubmed: 34099103 pmcid: 8238507
Zhang H, et al. The significance of EEG Alpha Oscillation Spectral Power and Beta Oscillation Phase synchronization for diagnosing probable Alzheimer Disease. Front Aging Neurosci. 2021. https://doi.org/10.3389/fnagi.2021.631587 .
doi: 10.3389/fnagi.2021.631587 pubmed: 36226304 pmcid: 8740294
Gaubert S, et al. EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease. Brain. 2019. https://doi.org/10.1093/brain/awz150 .
doi: 10.1093/brain/awz150 pubmed: 31211359
Meghdadi AH, et al. Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment. PLoS ONE. 2021. https://doi.org/10.1371/journal.pone.0244180 .
doi: 10.1371/journal.pone.0244180 pubmed: 33544703 pmcid: 7864432
Hohaia W, et al. Occipital alpha-band brain waves when the eyes are closed are shaped by ongoing visual processes. Sci Rep. 2022. https://doi.org/10.1038/s41598-022-05289-6 .
doi: 10.1038/s41598-022-05289-6 pubmed: 35075196 pmcid: 8786963
Kopčanová M, et al. Resting-state EEG signatures of Alzheimer’s disease are driven by periodic but not aperiodic changes. Neurobiol Dis. 2024. https://doi.org/10.1016/j.nbd.2023.106380 .
doi: 10.1016/j.nbd.2023.106380 pubmed: 38114048
Azami H, et al. Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia. Alzheimer’s Res Therapy. 2023. https://doi.org/10.1186/s13195-023-01280-z .
doi: 10.1186/s13195-023-01280-z
Gedankien T, et al. Acetylcholine modulates the temporal dynamics of human theta oscillations during memory. Nat Commun. 2023. https://doi.org/10.1038/s41467-023-41025-y .
doi: 10.1038/s41467-023-41025-y pubmed: 37648692 pmcid: 10469188
Whitehouse PJ, et al. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 1981. https://doi.org/10.1002/ana.410100203 .
doi: 10.1002/ana.410100203 pubmed: 7283399
Wirt RA, et al. Altered theta rhythm and hippocampal-cortical interactions underlie working memory deficits in a hyperglycemia risk factor model of Alzheimer’s disease. Commun Biology. 2021. https://doi.org/10.1038/s42003-021-02558-4 .
doi: 10.1038/s42003-021-02558-4
van Deursen JA, et al. Increased EEG gamma band activity in Alzheimer’s disease and mild cognitive impairment. J Neural Transm. 2008. https://doi.org/10.1007/s00702-008-0083-y .
doi: 10.1007/s00702-008-0083-y pubmed: 18607528
Fide E, et al. Hyperconnectivity matters in early-onset Alzheimer’s disease: a resting-state EEG connectivity study. Neurophysiol Clin. 2022. https://doi.org/10.1016/j.neucli.2022.10.003 .
doi: 10.1016/j.neucli.2022.10.003 pubmed: 36372646
Fide E, et al. Normalized Theta but increased Gamma activity after acetylcholinesterase inhibitor treatment in Alzheimer’s Disease: preliminary qEEG Study. Clin EEG Neurosci. 2023. https://doi.org/10.1177/15500594221120723 .
doi: 10.1177/15500594221120723 pubmed: 37563908
Aurtenetxe S, et al. Dysfunctional and compensatory duality in mild cognitive impairment during a continuous recognition memory task. Int J Psychophysiol. 2013. https://doi.org/10.1016/j.ijpsycho.2012.11.008 .
doi: 10.1016/j.ijpsycho.2012.11.008 pubmed: 23178844
Jiao B, et al. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology. Alzheimer’s Res Therapy. 2023. https://doi.org/10.1186/s13195-023-01181-1 .
doi: 10.1186/s13195-023-01181-1
Tzimourta KD, et al. Analysis of electroencephalographic signals complexity regarding Alzheimer’s Disease. Comput Electr Eng. 2019. https://doi.org/10.1016/j.compeleceng.2019.03.018 .
doi: 10.1016/j.compeleceng.2019.03.018
Kim S-P. (2018). Preprocessing of EEG, pp. 15–33.
Moretti, D. (2015). Association of EEG, MRI, and regional blood flow biomarkers is predictive of prodromal Alzheimer’s disease. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/NDT.S93253 .

Auteurs

Chowtapalle Anuraag Chetty (CA)

Centre for Brain Research, Indian Institute of Science, CV Raman Avenue, Bangalore, 560 012, India.

Harsha Bhardwaj (H)

Centre for Brain Research, Indian Institute of Science, CV Raman Avenue, Bangalore, 560 012, India.
Manipal Academy of Higher Education, Manipal, 576104, India.

G Pradeep Kumar (GP)

Centre for Brain Research, Indian Institute of Science, CV Raman Avenue, Bangalore, 560 012, India.

T Devanand (T)

Centre for Brain Research, Indian Institute of Science, CV Raman Avenue, Bangalore, 560 012, India.

C S Aswin Sekhar (CSA)

Centre for Brain Research, Indian Institute of Science, CV Raman Avenue, Bangalore, 560 012, India.

Tuba Aktürk (T)

Neuroscience Research Center, Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, 34810, Turkey.

Ilayda Kiyi (I)

Department of Neuroscience, Health Sciences Institute, Dokuz Eylül University, Izmir, 35330, Turkey.

Görsev Yener (G)

Faculty of Medicine, Izmir University of Economics, Izmir, 35330, Turkey.
Brain Dynamics Research Center, Dokuz Eylül University, Izmir, 35330, Turkey.
Biomedicine and Genome Center, Izmir, 35340, Turkey.

Bahar Güntekin (B)

Neuroscience Research Center, Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, 34810, Turkey.
Department of Biophysics, School of Medicine, Istanbul Medipol University, Istanbul, 34810, Turkey.

Justin Joseph (J)

Centre for Brain Research, Indian Institute of Science, CV Raman Avenue, Bangalore, 560 012, India.

Chinnakkaruppan Adaikkan (C)

Centre for Brain Research, Indian Institute of Science, CV Raman Avenue, Bangalore, 560 012, India. chinna@cbr-iisc.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH